Form 4 for CNMD CONMED Corp
Accepted 2022-12-12 00:00:00 ET · period of report 2022-12-09 · accession 0001127602-22-027324 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-12-12 | 2022-12-09 | CNMD | Garner Todd W | EVP, CFO | S - Sale+OE | $89.31 | -4,500 | 1 | -100% | -$401.9K |
| D | 2022-12-12 | 2022-12-09 | CNMD | Garner Todd W | EVP, CFO | M - OptEx | $50.61 | +4,500 | 4,501 | +450,000% | +$227.7K |
| D | 2022-12-12 | 2022-12-09 | CNMD | Garner Todd W | EVP, CFO | M - OptEx | $0.00 | -4,500 | 35.1K | -11% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-12-09 | S | D | 4,500 | $89.31 | 1 | D | — | — | |
| 2 | Common | Common Stock | 2022-12-09 | M | A | 4,500 | $50.61 | 4,501 | D | — | — | |
| 3 | Derivative | Options To Purchase Common Stock | 2022-12-09 | M | D | 4,500 | $0.00 | 35,100 | D | $50.61 · — to 2028-01-02 | 4,500 Common Stock | (F2) Each Stock Option represents a contingent right to receive one share of common stock, par value $0.001, per share of Conmed Corporation (the "Company") and was granted outside of the Company's existing equity plan as "employment inducement grants" under NASDAQ Listing Rule 5635(c)(4) and vest in equal amounts (20%) over a five year period on the January 2 anniversary date of the award, as further described in the Current Report filed with the SEC by the Company on January 2, 2018. |